Blood Pressure News
-
Perrigo Co. jumped in New York, pushing the premium over the generic drugmaker’s Israel-traded shares to the widest in six months, on speculation the U.S. will make more pharmaceuticals available without a prescription.
-
An imprisoned Ethiopian opposition leader needs urgent medical attention 12 days after being assaulted in his cell, former President Negasso Gidada said.
-
Chelsea Therapeutics International Ltd. surged the most in almost seven years after the company’s drug to treat a condition that can cause dizziness in people with central nervous system disorders won the backing of a U.S. advisory panel.
-
Chelsea Therapeutics International Ltd.’s drug to treat a condition that can cause dizziness in people with nervous system disorders may be unsafe and shouldn’t be approved, U.S. regulators said. The company’s shares fell.
-
Novartis AG said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators.
-
Four months after I walked into a lab at Harvard University and gave a vial of blood to have my genome sequenced, my search to understand my DNA led me to Mark Sanders, a former Indiana firefighter.
-
The “Taste of Iowa” menu for Chinese Vice President Xi Jinping’s dinner in Des Moines tonight isn’t going down well with nutritionists. They say bacon- lettuce-and-tomato bites and potatoes stuffed with white cheddar are dietary perils high in calories, sodium and saturated fat.
-
Actelion Ltd., the Swiss maker of the Tracleer lung treatment, aims for profit this year to be unchanged as the economic crisis puts pressure on drug prices and the company loses market share to Gilead Sciences Inc.
-
On Saturday night, chefs Daniel Boulud, Tom Colicchio, Daniel Humm, David Bouley and Florian Bellanger gathered in Bouley’s test kitchen in Tribeca to prepare a meal for 50 guests.
-
Jack Sappenfield was driving in rural Oklahoma on Father’s Day 2009 when he lost control of the left side of his body. Alarmed and dizzy, he quickly turned back to a small local hospital.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page